sorafenib has been researched along with Cytomegalovirus in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cinatl, J; Dauth, S; Doerr, HW; Löschmann, N; Michaelis, M; Nevels, M; Paulus, C; Stange, E | 1 |
1 other study(ies) available for sorafenib and Cytomegalovirus
Article | Year |
---|---|
The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication.
Topics: Benzenesulfonates; Cytomegalovirus; DNA Primers; Genes, Immediate-Early; Humans; Immunoblotting; Luciferases; Niacinamide; Phenylurea Compounds; Promoter Regions, Genetic; Protein Kinase Inhibitors; Pyridines; raf Kinases; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sorafenib; Virus Replication | 2011 |